Recruiting

Observational StudyVolumetric Impedance to Guide Stroke Response

Sponsor:

Cerebrotech Medical Systems, Inc.

Code:

NCT03767842

Conditions

Stroke, Acute

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Visor System

Study Details

Brief summary:

Assess the ability of the Visor System to detect hemispheric bioimpedance asymmetry

Conditions

Stroke, Acute

Study ID

NCT03767842

Start date

Jul 18, 2018

Status verified date

Dec, 2018

Completion date

Mar 31, 2019

Anticipated

Primary completion date

Mar 31, 2019

Anticipated

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

Being evaluated as a suspected stroke

Exclusion Criteria:

-

Study Design

Enrollment

316 participants

Anticipated

Interventions and Outcome Measures

Interventions

Visor System

Subjects are monitored one time with the Visor System.

Primary outcome measure

Hemispheric bioimpedance asymmetry sensitivity and specificity [ Time Frame: At the time of device monitoring - day 0 ]

Central Contacts and Locations

Central contacts

Adrian Parker

978-409-0451 aparker@vastrax.com

Locations

University of Buffalo Neurosurgery

Recruiting

Buffalo, New York, United States, 14203

Contacts

Adrian Parker

978-409-0451 aparker@vastrax.com

More Information

Sponsor

Cerebrotech Medical Systems, Inc.

Last update posted

Dec 7, 2018

Last verified

Dec, 2018

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Cerebrotech Medical Systems, Inc. on 2018-12-07.